← All trials
NCT04641858
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 3, 2020
- Primary completion
- Feb 28, 2022
- Completion date
- Mar 31, 2022
- First posted
- Nov 24, 2020
- Last posted
- Dec 4, 2020
- Enrollment
- 1050
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- University of Southern DenmarkLead sponsor
- Bandim Health ProjectCollaborator
- University of Southern DenmarkOverall official - principal investigator
- European and Developing Countries Clinical Trials Partnership (EDCTP)Collaborator
- Centro de Investigacao em Saude de ManhicaCollaborator
- University of Cape VerdeCollaborator
- Nova UniversityCollaborator
- Government of Cape VerdeCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.